Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Immediate Therapeutic Response of Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Symptomatic Uterine Fibroids
Authors:
- Hyo K. LimHLHyo K. Lim
- Jae-Hun KimJKJae-Hun Kim
- Hyunchul RhimHRHyunchul Rhim
- Byung Kwan ParkBPByung Kwan Park
- Bilgin KeserciBKBilgin Keserci
- Max O. KöhlerMKMax O. Köhler
- Duk-Soo BaeDBDuk-Soo Bae
- Byoung-Gie KimBKByoung-Gie Kim
- Jeong-Won LeeJLJeong-Won Lee
- Tae-Joong KimTKTae-Joong Kim
- Shunmugavelu SokkaSSShunmugavelu Sokka
- 1 October 2011
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 46 (10) , 639-647
Abstract
To evaluate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in the prediction of the immediate therapeutic response of MR-guided high-intensity focused ultrasound (HIFU) therapy in the treatment of symptomatic uterine fibroids Institutional review board approved this study, and informed consent was obtained from all participants. A total of 10 symptomatic uterine fibroids (diameter: mean, 8.9 cm; range, 4.7–12 cm) in 10 female patients (mean age, 42.2 years) were treated with MR-HIFU therapy using the volumetric ablation technique. DCE-MRI and conventional contrast-enhanced MRI were obtained as a baseline and as an immediate follow-up study, respectively. After regions of interest of each treatment cell were properly registered to both MRI studies, DCE-MRI parameters (Ktrans, ve, vp) and operator-controllable therapy parameters (power, treatment cell size, sonication depth) were investigated on a cell-by-cell basis to reflect tissue inhomogeneity. Two types of ablation efficacy indices (volume of 240 equivalent minutes at 43°C/treatment-cell volume, nonperfused volume/treatment-cell volume) were then correlated with those parameters using multiple linear regression analysis to determine which factors were significant predictors for ablation efficacy. We used 293 treatment cells (4 mm, n = 12; 8 mm, n = 115; 12 mm, n = 149; 16 mm, n = 17), and all of them were analyzable. Ablation efficacies were 1.06 ± 0.58 and 0.67 ± 0.39. Ktrans (B = −12.035, P Conclusions: A higher Ktrans value at baseline DCE-MRI suggested a poor ablation efficacy of MR-HIFU therapy for symptomatic uterine fibroids.Keywords
This publication has 32 references indexed in Scilit:
- Leiomyoma Shrinkage After MRI-Guided Focused Ultrasound Treatment: Report of 80 PatientsAmerican Journal of Roentgenology, 2010
- Improved Volumetric MR-HIFU Ablation by Robust Binary Feedback ControlIEEE Transactions on Biomedical Engineering, 2009
- Volumetric HIFU ablation under 3D guidance of rapid MRI thermometryMedical Physics, 2009
- Uterine Leiomyomas: MR Imaging–guided Focused Ultrasound Surgery—Imaging Predictors of SuccessRadiology, 2008
- High-Intensity Focused Ultrasound Therapy: an Overview for RadiologistsKorean Journal of Radiology, 2008
- Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: From six to twelve months after volume reductionJournal of Minimally Invasive Gynecology, 2007
- Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance imagesAmerican Journal of Obstetrics and Gynecology, 2007
- Therapeutic applications of ultrasoundProgress in Biophysics and Molecular Biology, 2007
- Focused ultrasound treatment of uterine fibroid tumors: Safety and feasibility of a noninvasive thermoablative techniqueAmerican Journal of Obstetrics and Gynecology, 2003
- MR Imaging–guided Focused Ultrasound Surgery of Uterine Leiomyomas: A Feasibility StudyRadiology, 2003